Reporting from PTCOG 2012

OncoLink reporters provide up-to-date coverage of the annual Particle Therapy Cooperative Group (PTCOG 51) meeting in NCC, Goyang and Seoul, South Korea, May, 14-19, 2012.

Analysis of Proton Therapy Technique Robustness for Prostate Plans Based on CT Surveillance Carbon vs. Proton for Innovative Applications of Particle Beam Therapy Compilation of Worldwide Past and Current Clinical Trials in Proton and Carbon Beam Therapy Concurrent Dose-Escalated Proton Therapy and IMRT for Sinonasal Cancer: Initial Clinical Experience Eye Tracking and Gating System for Proton Therapy of Uveal Melanomas High Dose Proton Therapy for Soft Tissue Sarcoma of Trunk Type of Session: Scientific Session How much is the Proton Range Uncertainty? An End-to-end Study Using Various Animal Tissues Long Term Results of Proton Beam Radiotherapy for Clival Chordomas/Chondrosarcomas Long-Term Follow-Up on Phase II Study of High-Dose Proton/Photon Radiotherapy for Spine Sarcomas MRI Changes in Pediatric Patients with Low Grade Gliomas Treated with Proton or Photon Radiotherapy Panel Discussion: Particle Beam Scanning - The New Frontier in Particle Therapy Preliminary Patient Reported Outcomes after Proton Therapy for Prostate Cancer Promising Survival in Patients with Stage III NSCLC Treated with 74 GyE Proton Therapy/Chemotherapy Proton Therapy for Craniopharyngioma in Children: the Orsay Proton Centre Experience Proton Therapy of Cancers of the Nasal Cavity and Paranasal Sinuses Secondary Neutron Doses Received by Pediatric Patients during intracranial Proton Therapy Treatment The Value of Dose Constraints for Organs at Risk in Proton Therapy for Prostate Cancer Toxicities of Pelvic Organs after High-Dose, Spot Scanning Based Proton Therapy for Sacral Neoplasms